Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
20 04 2020
Historique:
received: 15 08 2019
revised: 05 12 2019
accepted: 12 12 2019
pubmed: 18 12 2019
medline: 1 4 2021
entrez: 18 12 2019
Statut: ppublish

Résumé

A single subanaesthetic dose of ketamine rapidly alleviates the symptoms of major depressive disorder (MDD). However, few studies have investigated the acute effects of ketamine on the BOLD pharmacological magnetic resonance imaging (phMRI) response and EEG spectra. In a randomised, double-blind, active placebo-controlled crossover trial, resting-state simultaneous EEG/fMRI was collected during infusion of ketamine or active placebo (remifentanil) in 30 participants with MDD. Montgomery-Asberg depression rating scale scores showed a significant antidepressant effect of ketamine compared to placebo (69% response rate). phMRI analyses showed BOLD signal increases in the anterior cingulate and medial prefrontal cortices and sensitivity of the decrease in subgenual anterior cingulate cortex (sgACC) BOLD signal to noise correction. EEG spectral analysis showed increased theta, high beta, low and high gamma power, and decreased delta, alpha, and low beta power with differing time-courses. Low beta and high gamma power time courses explained significant variance in the BOLD signal. Interestingly, the variance explained by high gamma power was significantly associated with non-response to ketamine, but significant associations were not found for other neurophysiological markers when noise correction was implemented. The results suggest that the decrease in sgACC BOLD signal is potentially noise and unrelated to ketamine's antidepressant effect, highlighting the importance of noise correction and multiple temporal regressors for phMRI analyses. The lack of effects significantly associated with antidepressant response suggests the phMRI methodology employed was unable to detect such effects, the effect sizes are relatively small, or that other processes, e.g. neural plasticity, underlie ketamine's antidepressant effect.

Identifiants

pubmed: 31843628
pii: S0278-5846(19)30689-X
doi: 10.1016/j.pnpbp.2019.109838
pii:
doi:

Substances chimiques

Anesthetics, Dissociative 0
Ketamine 690G0D6V8H

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109838

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no potential conflict of interest.

Auteurs

Rebecca McMillan (R)

School of Pharmacy, University of Auckland, New Zealand. Electronic address: rgra126@aucklanduni.ac.nz.

Rachael Sumner (R)

School of Pharmacy, University of Auckland, New Zealand.

Anna Forsyth (A)

School of Pharmacy, University of Auckland, New Zealand.

Doug Campbell (D)

Department of Anaesthesiology, Auckland District Health Board, New Zealand.

Gemma Malpas (G)

Department of Anaesthesiology, Auckland District Health Board, New Zealand.

Elizabeth Maxwell (E)

Department of Anaesthesiology, Auckland District Health Board, New Zealand.

Carolyn Deng (C)

Department of Anaesthesiology, Auckland District Health Board, New Zealand.

John Hay (J)

Department of Anaesthesiology, Auckland District Health Board, New Zealand.

Rhys Ponton (R)

School of Pharmacy, University of Auckland, New Zealand.

Frederick Sundram (F)

Department of Psychological Medicine, University of Auckland, New Zealand.

Suresh Muthukumaraswamy (S)

School of Pharmacy, University of Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH